AstraZeneca PLC Ordinary Shares

Documents

Financial656 concepts · 6,685 facts · Dec 2015 to Jun 2026

• Contingent consideration44 · Dec 2015 to Dec 2025
• Revenue35 · Dec 2015 to Jun 2026
• Deferred tax assets34 · Dec 2015 to Jun 2026
• Noncontrolling interests34 · Dec 2015 to Jun 2026
• Assets (IFRS)29 · Dec 2015 to Jun 2026
• Bank overdrafts classified as cash equivalents29 · Dec 2015 to Jun 2026
• Cash and cash equivalents29 · Dec 2015 to Jun 2026
• Cash and cash equivalents if different from statement of financial position29 · Dec 2015 to Jun 2026
• Cash collateral on financial derivatives29 · Dec 2015 to Jun 2026
• Cash collateral posted by the group29 · Dec 2015 to Jun 2026
• Current assets29 · Dec 2015 to Jun 2026
• Current borrowings and current portion of noncurrent borrowings (IFRS)29 · Dec 2015 to Jun 2026
• Current derivative financial assets (IFRS)29 · Dec 2015 to Jun 2026
• Current derivative financial liabilities (IFRS)29 · Dec 2015 to Jun 2026
• Current investments29 · Dec 2015 to Jun 2026
• Current liabilities29 · Dec 2015 to Jun 2026
• Current provisions (IFRS)29 · Dec 2015 to Jun 2026
• Deferred tax liabilities (IFRS)29 · Dec 2015 to Jun 2026
• Equity29 · Dec 2015 to Jun 2026
• Equity attributable to owners of parent (IFRS)29 · Dec 2015 to Jun 2026
• Goodwill (IFRS)29 · Dec 2015 to Jun 2026
• Intangible assets other than goodwill29 · Dec 2015 to Jun 2026
• Inventories29 · Dec 2015 to Jun 2026
• Investment accounted for using equity method29 · Dec 2015 to Jun 2026

Product25 concepts · 4,729 facts · Dec 2015 to Jun 2026

• Revenue2,310 · Dec 2016 to Jun 2022
• Revenue from sale of goods (IFRS)1,377 · Dec 2015 to Jun 2026
• World622 · Jun 2021 to Jun 2026
• Total Oncology223 · Mar 2020 to Jun 2021
• Collaboration Revenue55 · Dec 2017 to Dec 2025
• Enhertu25 · Dec 2021 to Dec 2025
• Gains on disposal of intangible assets24 · Dec 2015 to Dec 2021
• Revenue that was included in contract liability balance at beginning of period15 · Dec 2021 to Dec 2025
• Revenue from government grants14 · Dec 2020 to Dec 2024
• US13 · Dec 2021 to Dec 2023
• Other operating income expense12 · Dec 2019 to Dec 2020
• Miscellaneous other operating income (IFRS)8 · Dec 2018 to Dec 2025
• Impairment loss recognised in profit or loss intangible assets other than goodwill5 · Dec 2017
• Intangible Assets (excluding Goodwill)5 · Dec 2017 to Dec 2018
• Other operating income and expense4 · Dec 2020 to Dec 2023
• Research and development expense (IFRS)4 · Dec 2020 to Dec 2021
• Movement in profit participation liability3 · Dec 2019 to Dec 2023
• Consideration paid received2 · Dec 2020 to Dec 2021
• Reversal of impairment loss2 · Dec 2019 to Dec 2021
• Cash flows from used in operating activities1 · Dec 2020
• Cost of sales1 · Dec 2024
• Increase in impairment charge due to changes in assumptions of valuation model1 · Dec 2018
• Inventory writedown20111 · Dec 2024
• Synagis1 · Dec 2021

IFRS129 concepts · 1,055 facts · Dec 2020 to Dec 2025

• Equity Change: Share-Based Payment Transactions54 · Dec 2020 to Dec 2025
• Issue of Equity54 · Dec 2020 to Dec 2025
• Net Income54 · Dec 2020 to Dec 2025
• Other Comprehensive Income54 · Dec 2020 to Dec 2025
• Stockholders Equity54 · Dec 2020 to Dec 2025
• Total Changes in Equity54 · Dec 2020 to Dec 2025
• Dividends Recognised as Distributions to Noncontrolling Interests27 · Dec 2023 to Dec 2025
• Equity Change: Ownership Changes Without Loss of Control18 · Dec 2024 to Dec 2025
• Equity Change: Treasury Share Transactions18 · Dec 2024 to Dec 2025
• Accounts Payable6 · Dec 2020 to Dec 2025
• Adjustment: Change in Inventories6 · Dec 2020 to Dec 2025
• Adjustment: Change in Trade and Other Receivables6 · Dec 2020 to Dec 2025
• Capital Expenditures6 · Dec 2020 to Dec 2025
• Capital Redemption Reserve6 · Dec 2020 to Dec 2025
• Cash and Cash Equivalents (Cash Flow Statement)6 · Dec 2020 to Dec 2025
• Cash and Equivalents6 · Dec 2020 to Dec 2025
• Cash Generated from Operations6 · Dec 2020 to Dec 2025
• Comprehensive Income Attributable to Noncontrolling Interests6 · Dec 2020 to Dec 2025
• Comprehensive Income Attributable to Owners of Parent6 · Dec 2020 to Dec 2025
• Cost of Revenue6 · Dec 2020 to Dec 2025
• Current Borrowings and Current Portion of Noncurrent Borrowings6 · Dec 2020 to Dec 2025
• Current Derivative Financial Assets6 · Dec 2020 to Dec 2025
• Current Derivative Financial Liabilities6 · Dec 2020 to Dec 2025
• Current Lease Liabilities6 · Dec 2020 to Dec 2025

Geography37 concepts · 770 facts · Dec 2015 to Dec 2025

• Revenue282 · Dec 2015 to Dec 2025
• Revenue from sale of goods (IFRS)52 · Dec 2015 to Dec 2023
• Property, Plant & Equipment, Net49 · Dec 2016 to Dec 2025
• Profit loss before tax48 · Dec 2015 to Dec 2025
• Profit loss from operating activities48 · Dec 2015 to Dec 2025
• Average number of employees46 · Dec 2015 to Dec 2025
• Total Assets41 · Dec 2016 to Dec 2025
• World14 · Jun 2021 to Jun 2023
• Applicable tax rate11 · Dec 2017 to Dec 2022
• Actuarial gains losses arising from changes in financial assumptions before tax defined benefit plans10 · Dec 2023 to Dec 2025
• Actuarial gains losses arising from experience adjustments before tax defined benefit plans10 · Dec 2023 to Dec 2025
• Current service cost defined benefit plans10 · Dec 2023 to Dec 2025
• Interest expense defined benefit plans10 · Dec 2023 to Dec 2025
• Interest income defined benefit plans10 · Dec 2023 to Dec 2025
• Other comprehensive income before tax gains losses on remeasurements of defined benefit plans10 · Dec 2023 to Dec 2025
• Postemployment benefit expense defined benefit plans10 · Dec 2023 to Dec 2025
• Total charge to operating profit10 · Dec 2023 to Dec 2025
• Interest expense income defined benefit plans9 · Dec 2023 to Dec 2025
• Internal transfers of intellectual property9 · Dec 2017 to Dec 2022
• Past service cost defined benefit plans9 · Dec 2023 to Dec 2025
• Return on plan assets excluding interest income or expense before tax defined benefit plans9 · Dec 2023 to Dec 2025
• US9 · Dec 2016 to Dec 2023
• Tax effect from change in tax rate8 · Dec 2017 to Dec 2022
• Number of significant wholesalers7 · Dec 2019 to Dec 2025

Products and services194 members · 4,729 facts

• Crestor106 · Dec 2015 to Jun 2026
• Brilinta103 · Dec 2015 to Jun 2026
• Farxiga103 · Dec 2015 to Jun 2026
• Oncology Products103 · Dec 2015 to Jun 2026
• Other Products103 · Dec 2015 to Jun 2026
• Respiratory Products103 · Dec 2015 to Jun 2026
• Symbicort103 · Dec 2015 to Jun 2026
• Tagrisso103 · Dec 2015 to Jun 2026
• Zoladex103 · Dec 2015 to Jun 2026
• Lynparza102 · Dec 2015 to Jun 2026
• Nexium102 · Dec 2015 to Dec 2025
• Pulmicort102 · Dec 2015 to Jun 2026
• Other Respiratory Products101 · Dec 2015 to Jun 2026
• Other Products Others98 · Dec 2015 to Dec 2025
• Onglyza95 · Dec 2015 to Dec 2023
• Faslodex94 · Dec 2015 to Dec 2023
• Seloken Toprol Xl94 · Dec 2015 to Dec 2024
• Other Oncology Products92 · Dec 2015 to Jun 2026
• Daliresp Daxas91 · Dec 2015 to Dec 2023
• Fasenra91 · Dec 2017 to Jun 2026
• Bydureon90 · Dec 2015 to Dec 2023
• Imfinzi90 · Dec 2017 to Jun 2026
• Synagis88 · Dec 2015 to Dec 2025
• Calquence79 · Dec 2017 to Jun 2026
• Iressa79 · Dec 2015 to Dec 2022
• Lokelma77 · Dec 2019 to Jun 2026
• Breztri69 · Dec 2019 to Jun 2026
• Arimidex68 · Dec 2015 to Dec 2022
• Casodex68 · Dec 2015 to Dec 2022
• Bevespi67 · Dec 2017 to Dec 2023
• Byetta56 · Dec 2015 to Dec 2021
• Cardiovascular And Metabolic Diseases Products55 · Dec 2015 to Dec 2025
• Atacand53 · Dec 2015 to Dec 2021
• Koselugo53 · Jun 2020 to Jun 2026
• Other Cardiovascular And Metabolic Diseases Products53 · Dec 2015 to Dec 2025
• Losec Prilosec52 · Dec 2015 to Dec 2021
• Seroquel Xr Ir52 · Dec 2016 to Dec 2021
• Flumist50 · Dec 2019 to Jun 2026
• Rare Diseases50 · Dec 2020 to Jun 2026
• Cardiovascular Renal And Metabolism Products48 · Mar 2020 to Jun 2026
• Soliris48 · Dec 2021 to Jun 2026
• Strensiq48 · Dec 2021 to Jun 2026
• Other Cardiovascular Renal And Metabolism Products46 · Mar 2020 to Jun 2026
• Kanuma42 · Dec 2021 to Dec 2024
• Other Diabetes42 · Dec 2017 to Dec 2021
• Enhertu41 · Mar 2021 to Jun 2026
• Andexxa35 · Dec 2021 to Dec 2024
• Roxadustat29 · Mar 2021 to Jun 2026
• Saphnelo29 · Dec 2021 to Jun 2026
• Ultomiris29 · Jun 2022 to Jun 2026
• Vaxzevria29 · Dec 2020 to Dec 2024
• Flumist Fluenz26 · Dec 2015 to Dec 2020
• Covid19 Mabs23 · Dec 2021 to Dec 2024
• Vaccines And Immune Therapies22 · Dec 2020 to Dec 2025
• Tezspire21 · Dec 2022 to Jun 2026
• Utomiris20 · Dec 2021 to Dec 2023
• Vaccine And Infection20 · Jun 2022 to Jun 2025
• Tudorza Eklira18 · Dec 2015 to Dec 2018
• Duaklir16 · Dec 2016 to Dec 2019
• Evusheld16 · Dec 2020 to Dec 2022
• Breztri15 · Jun 2020 to Jun 2022
• Brilinta15 · Jun 2020 to Jun 2022
• Calquence15 · Jun 2020 to Jun 2022
• Crestor15 · Jun 2020 to Jun 2022
• Daliresp daxas15 · Jun 2020 to Jun 2022
• Farxiga15 · Jun 2020 to Jun 2022
• Fasenra15 · Jun 2020 to Jun 2022
• Faslodex15 · Jun 2020 to Jun 2022
• Imfinzi15 · Jun 2020 to Jun 2022
• Iressa15 · Jun 2020 to Jun 2022
• Lokelma15 · Jun 2020 to Jun 2022
• Lynparza15 · Jun 2020 to Jun 2022
• Nexium15 · Jun 2020 to Jun 2022
• Onglyza15 · Jun 2020 to Jun 2022
• Other products others15 · Jun 2020 to Jun 2022
• Other respiratory products15 · Jun 2020 to Jun 2022
• Pulmicort15 · Jun 2020 to Jun 2022
• Symbicort15 · Jun 2020 to Jun 2022
• Tagrisso15 · Jun 2020 to Jun 2022
• Zoladex15 · Jun 2020 to Jun 2022
• Beyfortus15 · Jun 2023 to Jun 2026
• Bydureon14 · Jun 2020 to Jun 2022
• Other cardiovascular renal and metabolism products14 · Jun 2020 to Jun 2022
• Other oncology products14 · Jun 2020 to Jun 2022
• Seloken toprol xl14 · Jun 2020 to Jun 2022
• Arimidex13 · Jun 2020 to Jun 2022
• Bevespi13 · Jun 2020 to Jun 2022
• Casodex13 · Jun 2020 to Jun 2022
• Synagis13 · Jun 2020 to Jun 2022
• Covid1913 · Dec 2020 to Dec 2021
• Byetta12 · Dec 2017 to Jun 2021
• Koselugo12 · Jun 2020 to Jun 2022
• Orpathys11 · Jun 2022 to Dec 2024
• Flumist10 · Sep 2020 to Jun 2022
• Other diabetes10 · Jun 2020 to Jun 2021
• Seroquel xr ir10 · Jun 2020 to Jun 2021
• Covid19 Vaccine Astrazeneca C19vaz10 · Dec 2020 to Dec 2022
• Imjudo10 · Dec 2022 to Jun 2026
• Atacand9 · Jun 2020 to Jun 2021
• Losec prilosec9 · Jun 2020 to Jun 2021
• Movantik Moventig9 · Dec 2016 to Dec 2018
• Truqap9 · Dec 2023 to Jun 2026
• Enhertu8 · Mar 2021 to Jun 2022
• Brazikumab8 · Dec 2018 to Dec 2025
• Other Collaboration Revenue8 · Dec 2017 to Dec 2025
• Other Royalty Income8 · Dec 2020 to Dec 2025
• Vaxzeveria8 · Jun 2022
• Airsupra7 · Dec 2023 to Jun 2026
• Seloken7 · Dec 2023 to Jun 2026
• Covid19 vaccine astrazeneca c19vaz6 · Mar 2021 to Jun 2021
• Roxadustat6 · Mar 2021 to Jun 2022
• Ophatys6 · Dec 2021 to Dec 2022
• Orphatys6 · Dec 2021 to Dec 2023
• Wainua6 · Jun 2024 to Jun 2026
• Evusheld5 · Jun 2022
• Kanuma5 · Jun 2022
• Soliris5 · Jun 2022
• Strensiq5 · Jun 2022
• Ultomiris5 · Jun 2022
• Vaxzeveria5 · Jun 2022
• Collaboration Revenue5 · Dec 2021 to Dec 2025
• Other Alliance Revenue5 · Dec 2021 to Dec 2025
• Other Revenue5 · Dec 2021 to Dec 2025
• Royal Revenue5 · Dec 2017 to Dec 2021
• Andexxa4 · Jun 2022
• Saphnelo4 · Jun 2022
• Movantik4 · Dec 2015 to Dec 2017
• Others Vaccines And Immune Therapies4 · Dec 2022 to Dec 2025
• Profit Share Revenue From Product Sales By Collaboration Partners4 · Dec 2019 to Dec 2022
• Rare Disease Other4 · Jun 2025 to Jun 2026
• Symlin4 · Dec 2017 to Dec 2018
• Vaxzevria Royalties4 · Dec 2021 to Dec 2022
• Azd74423 · Dec 2020 to Dec 2021
• Contract Revenue3 · Dec 2021 to Dec 2023
• Contractual Managed Care And Medicare3 · Dec 2021 to Dec 2023
• Datroway3 · Dec 2025 to Jun 2026
• Diprivan3 · Dec 2015 to Dec 2017
• Enhertu Alliance Revenue3 · Dec 2020 to Dec 2022
• Evushield3 · Dec 2021
• Farxiga Sales Milestones3 · Dec 2023 to Dec 2025
• Local Anaesthetics3 · Dec 2015 to Dec 2017
• Merrem3 · Dec 2015 to Dec 2017
• Milestone Revenue3 · Dec 2017 to Dec 2019
• Other Rare Disease Products3 · Dec 2023 to Dec 2025
• Plendil3 · Dec 2015 to Dec 2017
• Product Sales Excluding Rare Diseases3 · Dec 2021 to Dec 2023
• Regulatory Medicaid And State Programmes3 · Dec 2021 to Dec 2023
• Roxadustat Alliance Revenue3 · Dec 2020 to Dec 2022
• Seroquel Ir3 · Dec 2015 to Dec 2017
• Seroquel Xr3 · Dec 2015 to Dec 2017
• Arimidex And Casodex2 · Dec 2019
• Orpathys2 · Jun 2022
• Beyfortus Regulatory Milestones2 · Dec 2022 to Dec 2023
• Beyfortus Sales Milestones2 · Dec 2023 to Dec 2024
• Entocort2 · Dec 2015
• Hypertension Medicines2 · Dec 2020
• Ifrs Other Operating Income Expense2 · Dec 2019 to Dec 2020
• Infectious Disease2 · Jun 2026
• Infectious Disease Other2 · Jun 2026
• Launched Products2 · Dec 2019 to Dec 2021
• Losec2 · Dec 2019
• Lynparza Koselugo Msd Regulatory Milestone2 · Dec 2020 to Dec 2022
• Lynparza Koselugo Msd Sales Related Milestones2 · Dec 2020 to Dec 2021
• Lynparza Regulatory Milestones2 · Dec 2022 to Dec 2023
• Lynparza Sales Related Milestones2 · Dec 2021 to Dec 2024
• Nexium Sale Of Rights2 · Dec 2021 to Dec 2022
• Priority Review Voucher2 · Dec 2020
• Tralokinumab Sales Milestone2 · Dec 2022 to Dec 2023
• Upfront Revenue2 · Dec 2017 to Dec 2018
• Alvesco Omnaris And Zetonna1 · Dec 2018
• Anaesthetics Medicines Portfolio1 · Dec 2018
• Flumist fluenz1 · Dec 2017
• Movantik1 · Dec 2017
• Verinurad1 · Dec 2017
• Baxfendy1 · Jun 2026
• Brazikumab Licence Termination Funding1 · Dec 2020
• Caprelsa1 · Dec 2015
• Covid19 Mabs Licence Fees1 · Dec 2023
• Etcamah1 · Jun 2026
• Imdur1 · Dec 2016
• Inderal Tenormin Seloken And Omepral1 · Dec 2020
• Koselugo Sales Milestone1 · Dec 2024
• MEDI20701 · Dec 2016
• Monetisation Of Asset Previously Licensed1 · Dec 2020
• Myalept1 · Dec 2015
• Nexium And Vimovo1 · Dec 2020
• Pulmicort Flexhaler1 · Dec 2023
• Rhinocort1 · Dec 2016
• Seroquel And Seroquel Xr1 · Dec 2019
• Small Molecule Antibiotics1 · Dec 2016
• Tezspire Alliance Revenue1 · Dec 2022
• Tralokinumab1 · Dec 2017
• Verinurad1 · Dec 2017
• Zomig1 · Dec 2017

Geographical areas61 members · 767 facts

• Ifrs Country Gb59 · Dec 2015 to Dec 2023
• Ifrs Europe56 · Dec 2015 to Dec 2025
• Asia Africa And Australasia52 · Dec 2015 to Dec 2025
• Ifrs Americas52 · Dec 2015 to Dec 2025
• Ifrs Country Us46 · Dec 2015 to Dec 2023
• Country Of Domicile45 · Dec 2023 to Dec 2025
• SE40 · Dec 2018 to Dec 2025
• Other Countries22 · Dec 2024 to Dec 2025
• US20 · Dec 2017 to Dec 2025
• Europe Excluding United Kingdom19 · Dec 2020 to Dec 2025
• GB17 · Dec 2022 to Dec 2025
• Ifrs country gb16 · Dec 2016 to Dec 2023
• Emerging Markets16 · Dec 2016 to Dec 2023
• World Excluding Emerging Markets United States And Europe14 · Dec 2016 to Dec 2023
• Other Countries Prior To2024 Disaggregation13 · Dec 2023
• NL11 · Dec 2018 to Dec 2022
• Other Americas Excluding Us And Canada11 · Dec 2015 to Dec 2025
• Other Asia Africa And Australasia Excluding Australia China And Japan11 · Dec 2015 to Dec 2025
• Asia africa and australasia10 · Dec 2016 to Dec 2025
• Ifrs americas10 · Dec 2016 to Dec 2025
• Ifrs country us10 · Dec 2016 to Dec 2023
• Rest of world excluding uk sweden and us10 · Dec 2016 to Dec 2025
• Ifrs Country Ca10 · Dec 2015 to Dec 2023
• Ifrs Country Au9 · Dec 2015 to Dec 2023
• Ifrs Country Cn9 · Dec 2015 to Dec 2023
• Ifrs Country De9 · Dec 2015 to Dec 2023
• Ifrs Country Es9 · Dec 2015 to Dec 2023
• Ifrs Country Fr9 · Dec 2015 to Dec 2023
• Ifrs Country It9 · Dec 2015 to Dec 2023
• Ifrs Country Jp9 · Dec 2015 to Dec 2023
• Ifrs Country Se9 · Dec 2015 to Dec 2023
• Ifrs country se8 · Dec 2016 to Dec 2023
• Ifrs europe7 · Dec 2017 to Jun 2022
• External Uk7 · Dec 2015 to Dec 2021
• Other Continental Europe Excluding Belgium France Germany Italy Spain And Sweden7 · Dec 2015 to Dec 2021
• Gb6 · Dec 2023 to Dec 2025
• Established Row6 · Jun 2021 to Jun 2023
• Other Europe6 · Dec 2020 to Dec 2025
• Outside United Kingdom6 · Dec 2020 to Dec 2025
• Europe excluding united kingdom5 · Dec 2021 to Dec 2025
• AU4 · Dec 2022 to Dec 2025
• CA4 · Dec 2022 to Dec 2025
• CN4 · Dec 2022 to Dec 2025
• DE4 · Dec 2022 to Dec 2025
• ES4 · Dec 2022 to Dec 2025
• FR4 · Dec 2022 to Dec 2025
• IT4 · Dec 2022 to Dec 2025
• JP4 · Dec 2022 to Dec 2025
• Ifrs country ireland3 · Dec 2021 to Dec 2023
• Ie3 · Dec 2023 to Dec 2025
• Se3 · Dec 2023 to Dec 2025
• Us3 · Dec 2023 to Dec 2025
• Intra Group Americas3 · Dec 2015 to Dec 2017
• Intra Group Asia Africa And Australasia3 · Dec 2015 to Dec 2017
• Intra Group Continental Europe3 · Dec 2015 to Dec 2017
• Intra Group Uk3 · Dec 2015 to Dec 2017
• Netherlands And Sweden3 · Dec 2018 to Dec 2019
• Emerging markets2 · Jun 2021 to Jun 2022
• Established row2 · Jun 2021 to Jun 2022
• World excluding emerging markets united states and europe2 · Jun 2021 to Jun 2022
• Countries Other Than Uk And Netherlands2 · Dec 2021 to Dec 2022

Components of equity8 members · 344 facts

• Capital redemption reserve43 · Dec 2020 to Dec 2025
• Equity attributable to owners of parent43 · Dec 2020 to Dec 2025
• Issued capital43 · Dec 2020 to Dec 2025
• Merger reserve43 · Dec 2020 to Dec 2025
• Noncontrolling interests43 · Dec 2020 to Dec 2025
• Other reserves43 · Dec 2020 to Dec 2025
• Retained earnings43 · Dec 2020 to Dec 2025
• Share premium43 · Dec 2020 to Dec 2025

Statement geographical1 member · 3 facts

• Ifrs Country Jp3 · Dec 2017 to Dec 2019